FIM

476 posts

FIM banner
FIM

FIM

@FimMpn

Le FIM fédère les praticiens travaillant sur la Polyglobulie de Vaquez, la Thrombocytémie Essentielle, et la Myélofibrose #mpnsm Membre institut @CarnotOpale

Katılım Aralık 2015
31 Takip Edilen302 Takipçiler
FIM retweetledi
J.J. Kiladjian
J.J. Kiladjian@jjkiladjian·
Still time to register! Join us for this e-conference with world-class experts happy to share their knowledge in #MPNsm with you
J.J. Kiladjian tweet media
English
0
5
23
0
FIM
FIM@FimMpn·
Une pleine page sur les syndromes myéloprolifératifs cette semaine dans @ParisMatch pour mettre en lumière ces maladies du sang pas si rares #mpnsm @VivreAvecUneNmp
FIM tweet media
Français
2
10
25
0
FIM retweetledi
J.J. Kiladjian
J.J. Kiladjian@jjkiladjian·
So many new therapeutic options in development for #MPNsm #ASH21 Maybe time to redefine the precise role of phlebotomy as long term treatment for Polycythemia Vera? (il Guercino, Pinacoteca Nazionale di Bologna)
J.J. Kiladjian tweet media
English
1
5
29
0
FIM retweetledi
J.J. Kiladjian
J.J. Kiladjian@jjkiladjian·
Idea for future meetings, a session named: "Promising preliminary, early, precursory, preparatory but amazing results of studies with less than 3 patients analyzed" (apologies for this one, don't even have the excuse of the jet lag...)
J.J. Kiladjian tweet media
English
2
1
13
0
FIM retweetledi
J.J. Kiladjian
J.J. Kiladjian@jjkiladjian·
Sorry, but I'm already tired to hear in may presentations that adverse events are "tolerable" and "manageable"... from patients' point of view? Are we forced to use this language?
English
4
6
39
0
FIM retweetledi
J.J. Kiladjian
J.J. Kiladjian@jjkiladjian·
Superbe session @FimMpn sur SMP #mpnsm et dermatologie avec C. Lebbé @HopSaintLouis et JC Ianotto @CHRU_Brest, avec on l'espère des avancées à venir prochainement pour le traitement du prurit. Le suivi conjoint est en tous cas bénéfique pour les patients !
J.J. Kiladjian tweet media
Français
1
1
7
0
FIM
FIM@FimMpn·
C’est le grand jour ! Accueil de l’AG et journée du @FimMpn 2021 à partir de 9h30 ☕️😁 @jjkiladjian @valerie_ugo @LegrosLaurence @StephaneSgir @isabelle_plo #MPNSM
GIF
FIM@FimMpn

📢📢 Pas besoin de 🛵✈️🛴🚜🚘🛺🚲🏍🚆pour assister à la prochaine journée scientifique du @FimMpn qui aura lieu le 16 novembre 2021 en visioconférence! Inscription gratuite mais obligatoire Mail congresfim2021@prodarev.fr Ou forms.gle/enMoQPr6CNJbbL… #MPNSM Venez nombreux!

Français
0
1
7
0
FIM
FIM@FimMpn·
📢📢 Pas besoin de 🛵✈️🛴🚜🚘🛺🚲🏍🚆pour assister à la prochaine journée scientifique du @FimMpn qui aura lieu le 16 novembre 2021 en visioconférence! Inscription gratuite mais obligatoire Mail congresfim2021@prodarev.fr Ou forms.gle/enMoQPr6CNJbbL… #MPNSM Venez nombreux!
Français
0
1
1
0
FIM
FIM@FimMpn·
@AIHemato Avec plaisir ! On attend la liste
GIF
Français
0
0
1
0
FIM retweetledi
J.J. Kiladjian
J.J. Kiladjian@jjkiladjian·
Great discussion about #COVID vaccination and treatment with interferon at #ELN21 : seems that patients on IFN don't have more adverse events and are likely to develop highest levels of antibodies, consistent with its immunostimulant activity @AndreasHochhaus & Tiziano Barbui
English
1
4
22
0
FIM retweetledi
J.J. Kiladjian
J.J. Kiladjian@jjkiladjian·
In the French @FimMpn registry with more than 1788 #MPN patients, almost 300 patients were treated with interferon: only 9% had #COVID19 and none of them developed a severe case. Preliminary results will be presented at the @sfhemato annual meeting on Thursday, stay tuned!
J.J. Kiladjian tweet media
J.J. Kiladjian@jjkiladjian

Great discussion about #COVID vaccination and treatment with interferon at #ELN21 : seems that patients on IFN don't have more adverse events and are likely to develop highest levels of antibodies, consistent with its immunostimulant activity @AndreasHochhaus & Tiziano Barbui

English
0
3
10
0